Structure–activity Studies of WNT/Β-Catenin Inhibition in the Niclosamide Chemotype: Identification of Derivatives With Improved Drug Exposure

Bioorganic and Medicinal Chemistry - United Kingdom
doi 10.1016/j.bmc.2015.07.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Inhibition of WNT/Β-Catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2016English

Docking Studies Reveal Zerumbone Targets Β-Catenin of the WNT-Β-Catenin Pathway in Breast Cancer

Journal of the Serbian Chemical Society
Chemistry
2018English

Inhibition of Rac1 Activity by NSC23766 Prevents Cartilage Endplate Degeneration via WNT/Β‐catenin Pathway

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2020English

Correction: Niclosamide and Its Analogs Are Potent Inhibitors of WNT/Β-Catenin, mTOR and STAT3 Signaling in Ovarian Cancer

Oncotarget
Oncology
2018English

Inhibition of WNT-1 Signaling Induces Apoptosis in Β-Catenin-Deficient Mesothelioma Cells

Cancer Research
Cancer ResearchOncology
2004English

WNT/Β‑catenin Inhibition Reverses Multidrug Resistance in Pediatric Acute Lymphoblastic Leukemia

Oncology Reports
MedicineCancer ResearchOncology
2018English

“Wnt/Β-Catenin in GIST”—Letter

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Curcumin Suppresses Cell Proliferation Through Inhibition of the WNT/Β-Catenin Signaling Pathway in Medulloblastoma

Oncology Reports
MedicineCancer ResearchOncology
2014English

Novel Β-Carbolines Inhibit WNT/Β-Catenin Signaling

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy